Article Information
History
- May 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Michael Crompton1,
- Joanne K. Ferguson1,
- Raina D. Ramnath1,
- Karen L. Onions1,
- Anna S. Ogier1,
- Colin J. Down1,
- Laura Skinner1,
- Lauren K. Dixon1,
- Judit Sutak2,
- Steven J. Harper3,
- Paola Pontrelli4,
- Loreto Gesualdo4,
- Gavin I. Welsh1,
- Rebecca R. Foster1,
- Simon C. Satchell1,# and
- Matthew J. Butler1,#,*
- 1Bristol Renal, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
- 2Pathology Department, Southmead Hospital, Bristol, UK
- 3School of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, UK
- 4Division of Nephrology, Dialysis and Transplantation, Department of Emergency and Organ Transplantation, Aldo Moro University of Bari, Bari, Italy
- ↵*Corresponding Author
: Matthew J. Butler, Address: Bristol Renal, Dorothy Hodgkin Building, Whitson St, Bristol, BS1 3NY, UK, Telephone: +44 (0)117 331 3086, Email: matthew.butler{at}bristol.ac.uk
Posted May 19, 2021.
Early mineralocorticoid receptor antagonism in diabetic nephropathy limits albuminuria by preserving the glomerular endothelial glycocalyx
